AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2018
May 15, 2018
31982_dirs_2018-05-15_6c726021-b71e-4bd3-a1e6-5a9d614564f6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2018-05-14
Reporting Person: Trizzino John (SVP, CBO and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-14 | Common Stock | P | 50000 | $1.6399 | Acquired | 138965 | Direct |
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26